Global Red Biotechnology Market to 2030: Declining Prices of DNA Sequencing Drives Growth - ResearchAndMarkets.com
Robust pipeline is also expected to propel the growth of red biotechnology market on account of number of expected regulatory approvals in coming years.
- Robust pipeline is also expected to propel the growth of red biotechnology market on account of number of expected regulatory approvals in coming years.
- COVID- 19 pandemic also had a positive impact on the global market.
- By product, the monoclonal antibody is considered to be a relatively more mature and dominant segment compared to other products in the red biotechnology market.
- By end-user, the pharmaceutical & biotechnology companies accounted for majority of revenue in the red biotechnology industry.